Skip to main content
Atrás
Watch Compare

FENNEC PHARMACEUTICALS INC.

Calidad de datos: 100%
FENC
Nasdaq Manufacturing Chemicals
$6.42
▼ $0.07 (-1.08%)
Cap. Mercado: 221.33 M
Precio
$6.42
Cap. Mercado
221.33 M
Rango del Día
$6.25 — $6.47
Rango de 52 Semanas
$4.87 — $9.92
Volumen
44,526
Apertura $6.45
Promedio 50D / 200D
$7.68
16.40% below
Promedio 50D / 200D
$8.18
21.47% below

Quick Summary

Puntos Clave

Revenue grew 302.55% annually over 5 years — strong growth
Negative free cash flow of -12.47 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 308.64%

Crecimiento

Revenue Growth (5Y)
302.55%
Above sector avg (1.82%)
Revenue (1Y)-6.09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROIC-13.08%
Net Margin-21.82%
Op. Margin-14.07%

Seguridad

Debt / Equity
N/A
Current Ratio4.69
Interest Coverage-3.02

Valoración

PE (TTM)
-22.72
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -22.7 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % -21.8 -41.5
Rev Growth 5Y % 302.6 1.8
D/E — 0.3

ETFs Holding This Stock

BRUSX BRUSX
0.71% weight
GSMRX GSMRX
0.09% weight
GISMX GISMX
0.09% weight
GMSMX GMSMX
0.09% weight
FLQS FLQS
0.02% weight
IRSSX IRSSX
0.01% weight
VVICX VVICX
0.01% weight
IRCIX IRCIX
0.01% weight
IIRSX IIRSX
0.01% weight
IRSIX IRSIX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -6.09% Revenue Growth (3Y) 44.93%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 302.55% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 44.64 M Net Income (TTM) -9.74 M
ROE N/A ROA -20.70%
Gross Margin N/A Operating Margin -14.07%
Net Margin -21.82% Free Cash Flow (TTM) -12.47 M
ROIC -13.08% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.69
Interest Coverage -3.02 Asset Turnover 0.95
Working Capital 36.25 M Tangible Book Value -4.49 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -22.72 Forward P/E N/A
P/B Ratio N/A P/S Ratio 4.96
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5.64%
Market Cap 221.33 M Enterprise Value 218.76 M
Per Share
EPS (Diluted TTM) -0.34 Revenue / Share 1.29
FCF / Share -0.36 OCF / Share -0.36
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 128.05%
SBC-Adj. FCF -17.91 M Growth Momentum -308.64

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 44.64 M 47.54 M 21.25 M — 170,000.0
Net Income -9.74 M -436,000.0 -16.05 M -23.71 M -17.35 M
EPS (Diluted) -0.34 -0.02 -0.60 -0.90 -0.67
Gross Profit — — 19.99 M 1.45 M —
Operating Income -6.28 M 2.57 M -12.77 M -22.59 M -17.22 M
EBITDA — — — — —
R&D Expenses 250,000.0 307,000.0 56,000.0 3.53 M 4.98 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2.08 M 4.07 M 441,000.0 — —
Income Tax 106,000.0 365,000.0 — 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 70.55 M 44.95 M 26.86 M 26.94 M 22.41 M
Total Liabilities 35.08 M 50.82 M 38.49 M 29.51 M 6.64 M
Shareholders' Equity 35.47 M -5.87 M -11.62 M -2.57 M 15.77 M
Total Debt — 19.34 M 30.93 M 24.90 M —
Cash & Equivalents 36.79 M 26.63 M 13.27 M 23.77 M 21.10 M
Current Assets 67.04 M 44.12 M 26.86 M 26.73 M 22.39 M
Current Liabilities 10.52 M 6.92 M 7.55 M 4.61 M 1.65 M